Africa’s health security improves overall, but biosafety, biosecurity, and surge deployment still lag

The 2026 Africa Health Security Index reports broad improvement across the continent: 52 of 54 countries improved by at least one point, and the continental average rose from 32.4 to 41.5 out of 100 [5]. But the assessment also finds serious weaknesses in biosafety, biosecurity, dual-use oversight,…

Published

The 2026 Africa Health Security Index reports broad improvement across the continent: 52 of 54 countries improved by at least one point, and the continental average rose from 32.4 to 41.5 out of 100 [5]. But the assessment also finds serious weaknesses in biosafety, biosecurity, dual-use oversight, and rapid deployment of medical countermeasures, even as laboratories, surveillance, and sequencing capacity expand [5]. Why it matters: This matters because the region’s preparedness gains now appear to be shifting from building capacity to safely governing it and getting it into use during emergencies [5]. The evidence suggests that stronger institutions, logistics, and coordination may matter as much as new infrastructure. Key insights: Disease surveillance is the clearest area of progress, with wastewater or environmental surveillance documented in 52 countries and genomic-sequencing capacity in 48 [5]. | Average scores remain low for biosecurity (14.9), biosafety (18.2), and oversight of dual-use research (1.9) [5]. | South Africa’s biosecurity score rose from 6 to 54, but the article says data integration across human, animal, climate, and environmental systems still weakens early warning [5]. | Capacity to develop countermeasures is ahead of the capacity to deploy them, with development scoring 56.5 versus 20.7 for deployment; only 22% of countries have public emergency supply-surge plans [5]. Cheatsheet facts: What changed: Africa’s health security scores improved broadly, especially in detection and surveillance, but governance and deployment gaps remain [5]. | Why now: The assessment reflects five years of post-COVID investment and was completed before later international funding reductions, making the current baseline especially important [5]. | Watch next: Track whether countries publish emergency surge plans, strengthen biosafety/biosecurity oversight, and improve data integration for early warning [5].
Visual Cheatsheet Version A for Africa’s health security improves overall, but biosafety, biosecurity, and surge deployment still lag. Full text follows for assistive technology.
The 2026 Africa Health Security Index reports broad improvement across the continent: 52 of 54 countries improved by at least one point, and the continental average rose from 32.4 to 41.5 out of 100 [5]. But the assessment also finds serious weaknesses in biosafety, biosecurity, dual-use oversight, and rapid deployment of medical countermeasures, even as laboratories, surveillance, and sequencing capacity expand [5]. Why it matters: This matters because the region’s preparedness gains now appear to be shifting from building capacity to safely governing it and getting it into use during emergencies [5]. The evidence suggests that stronger institutions, logistics, and coordination may matter as much as new infrastructure. Key insights: Disease surveillance is the clearest area of progress, with wastewater or environmental surveillance documented in 52 countries and genomic-sequencing capacity in 48 [5]. | Average scores remain low for biosecurity (14.9), biosafety (18.2), and oversight of dual-use research (1.9) [5]. | South Africa’s biosecurity score rose from 6 to 54, but the article says data integration across human, animal, climate, and environmental systems still weakens early warning [5]. | Capacity to develop countermeasures is ahead of the capacity to deploy them, with development scoring 56.5 versus 20.7 for deployment; only 22% of countries have public emergency supply-surge plans [5]. Cheatsheet facts: What changed: Africa’s health security scores improved broadly, especially in detection and surveillance, but governance and deployment gaps remain [5]. | Why now: The assessment reflects five years of post-COVID investment and was completed before later international funding reductions, making the current baseline especially important [5]. | Watch next: Track whether countries publish emergency surge plans, strengthen biosafety/biosecurity oversight, and improve data integration for early warning [5].